The global market size was valued at US$ 6.78 billion in 2024 and is projected to reach US$ 9.45 billion by 2030, at a CAGR of 5.7% during the forecast period 2024-2030.
The United States market size was valued at US$ 2.34 billion in 2024 and is projected to reach US$ 3.12 billion by 2030, at a CAGR of 4.9% during the forecast period 2024-2030.
Medications for treating open-angle glaucoma.
Patient treatments reached 65 million in 2023. Combination drugs grow at 6.8% annually. Market saw 35% increase in preservative-free formulations. Approvals obtained in 45 countries. Future projects worth US$ 2.56 billion by 2026. North America leads with 38% market share.
Market Segmentation (by Type)
Prostaglandin Analogs (PGAs)
Combination of PGAs
Other
Market Segmentation (by Application)
Hospital
Clinic
Get free sample of this report at : https://www.24marketresearch.com/download-free-sample/8017964/global-openangle-glaucoma-therapeutics-2024-535
Locked
